Contact

Level Trailhead 96 Home About Services Legal Overview Research & Access State Landscape Contact Federal rules / state activity / safety Ibogaine Legal Status in the USA: Key Questions A plainspoken guide to the legal status of ibogaine, the limits of federal law, emerging research pathways, and the safety questions that matter before anyone considers ibogaine treatment. Independent information resource not medical or legal advice The short version Is ibogaine federally illegal in the US? A research pathway is not the same thing as broad legal access. Yes. In the United States, ibogaine is a Schedule I controlled substance under the Controlled Substances Act . The legal status means federal law prohibits its manufacture, possession, distribution, and ordinary clinical use outside highly restricted research. The country-by-country legal record shows why it is important not to assume that an option available elsewhere is lawful in the United States. A Schedule I controlled substance is placed in the federal category defined as having a high potential for abuse, no currently accepted medical use, and no accepted safety for use under medical supervision. The DEA scheduling framework explains the categories used under the Controlled Substances Act. The Drug Enforcement Administration maintains ibogaine’s classification despite advocacy seeking a re-evaluation of therapeutic uses. That federal prohibition shapes nearly every practical question about ibogaine treatment: who may handle it, where research can occur, what treatment centers can legally offer, and why many people look outside the country. A discussion of ibogaine HCl information may describe the compound, but description does not create a legal pathway to possession or treatment in the United States. The distinction matters because a natural plant and a psychoactive alkaloid can carry different cultural meanings while still falling inside a restrictive legal framework. Iboga is associated with indigenous com

Contact

Published channels